EIF4EBP1 and central nervous system cancer: Previously, the level of phosphor‐4E‐BP1Thr37/46 did not change with the treatment of rapamycin, because Thr37 and Thr46 sites of 4E‐BP1 are not sensitive to rapamycin in glioma cells [39, 40].